These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9796847

  • 1. Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus.
    Papo T, Parizot C, Ortova M, Piette JC, Frances C, Debre P, Godeau P, Gorochov G.
    Lupus; 1998; 7(7):455-61. PubMed ID: 9796847
    [Abstract] [Full Text] [Related]

  • 2. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ, Wang X, Wang XP, Li D, Ding F, Liu HX, Yu X, Li XF, Shu Q.
    Diagn Pathol; 2015 Jun 16; 10():71. PubMed ID: 26076826
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 16; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity.
    Courtney PA, Crockard AD, Williamson K, McConnell J, Kennedy RJ, Bell AL.
    Lupus; 1999 Oct 16; 8(7):508-13. PubMed ID: 10483027
    [Abstract] [Full Text] [Related]

  • 6. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun 16; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 7. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity.
    Bijl M, Horst G, Limburg PC, Kallenberg CG.
    Lupus; 2001 Jun 16; 10(12):866-72. PubMed ID: 11787876
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb 16; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 9. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar 16; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 10. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
    Chen X, Wang LL, Cai B, Chen J, Feng WH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep 16; 22(5):588-90. PubMed ID: 16948902
    [Abstract] [Full Text] [Related]

  • 11. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Sep 16; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 12. [Preliminary study on apoptosis and expression of apoptosis-related genes in peripheral blood lymphocytes of patients with systemic lupus erythematosus].
    Xie M, Wang Z, Liu X, Qiang O, Liu G.
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun 16; 30(2):192-5. PubMed ID: 12212057
    [Abstract] [Full Text] [Related]

  • 13. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Lee YH, Kim YR, Ji JD, Sohn J, Song GG.
    J Rheumatol; 2001 Sep 16; 28(9):2008-11. PubMed ID: 11550967
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M, Kim D, Oh M, Jeong H, Choi I.
    Lupus; 2009 May 16; 18(6):501-7. PubMed ID: 19395451
    [Abstract] [Full Text] [Related]

  • 15. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.
    Arthritis Rheum; 1997 Feb 16; 40(2):306-17. PubMed ID: 9041943
    [Abstract] [Full Text] [Related]

  • 16. Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE.
    Kovacs B, Szentendrei T, Bednarek JM, Pierson MC, Mountz JD, Vogelgesang SA, Tsokos GC.
    Clin Exp Rheumatol; 1997 Feb 16; 15(1):19-23. PubMed ID: 9093768
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT.
    Clin Exp Rheumatol; 2013 Feb 16; 31(2):172-9. PubMed ID: 23137515
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.
    Silvestris F, Grinello D, Tucci M, Cafforio P, Dammacco F.
    Lupus; 2003 Feb 16; 12(1):8-14. PubMed ID: 12587820
    [Abstract] [Full Text] [Related]

  • 19. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
    Arasteh JM, Sarvestani EK, Aflaki E, Amirghofran Z.
    Immunol Invest; 2010 Feb 16; 39(1):27-38. PubMed ID: 20064083
    [Abstract] [Full Text] [Related]

  • 20. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
    Lin XJ, Luo M, Cai XY.
    Zhonghua Yi Xue Za Zhi; 2011 Mar 08; 91(9):586-90. PubMed ID: 21600126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.